TRIAL OF ACTIVATED MARROW INFILTRATING LYMPHOCYTES ALONE OR IN CONJUNCTION WITH AN ALLOGENEIC GRANULOCYTE MACROPHAGE COLONY-STIMULATING FACTOR (GM-CSF)-BASED MYELOMA CELLULAR VACCINE IN THE AUTOLOGOUS TRANSPLANT SETTING IN MULTIPLE MYELOMA: